TWIST1 and acute myeloid leukemia: This was considered to be the results of increased susceptibility of leukemic blasts to cytarabine chemotherapy, as AML cells with Twist1 upregulation were confirmed to be more sensitive to the toxicity of cytarabine in vitro.